Evidence map›Paper›PMID 36319566›Full record

ArticleBrazilian journal of otorhinolaryngology

CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome.

Yousef Mohammadi, Simin Ahmadvand, Maryam Mirtalebi, Mohammad Javad Ashraf, Bijan Khademi, Abbas Ghaderi

Open access · goldAbstract read
In one paragraph

Article in Brazilian journal of otorhinolaryngology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yousef MohammadiShiraz University of Medical Sciences, School of Medicine, Department of Immunology, Shiraz, Iran; Shiraz University of Medical Sciences, School of Medicine, Shiraz Institute for Cancer Research, Shiraz, Iran.
Simin AhmadvandShiraz University of Medical Sciences, School of Medicine, Shiraz Institute for Cancer Research, Shiraz, Iran.
Maryam MirtalebiShiraz University of Medical Sciences, School of Medicine, Department of Pathology, Shiraz, Iran.
Mohammad Javad AshrafShiraz University of Medical Sciences, School of Medicine, Department of Pathology, Shiraz, Iran.
Bijan KhademiShiraz University of Medical Sciences, Otolaryngology Research Center, Department of Otorhinolaryngology, Shiraz, Iran.
Abbas GhaderiShiraz University of Medical Sciences, School of Medicine, Department of Immunology, Shiraz, Iran; Shiraz University of Medical Sciences, School of Medicine, Shiraz Institute for Cancer Research, Shiraz, Iran. Electronic address: ghaderia@sums.ac.ir.
Shiraz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe prognostic importance of Tumor-Infiltrating Lymphocytes (TILs) in the tumor microenvironment of various cancers is increasingly recognized. In the present study, we aimed to investigate the prognostic value of CD3+, CD4+, CD8+, and CD45RO + TILs and their relation to histopathological features in larynx squamous cell carcinoma.

methodsFormalin-Fixed and Paraffin-Embedded (FFPE) samples from 63 primary larynx squamous cell carcinoma patients were immunostained for CD3, CD4, CD8, and CD45RO expression. Positive cells in micrographs from Invasive Margin (IM) and Tumor Center (CT) of tissue specimens counted by ImageJ software and their correlation with disease outcome were analyzed.

resultsThe expression level of TILs subpopulations was associated with clinicopathological markers as well as Overall Survival (OS) and Disease-Free Survival (DFS). In multivariate analysis, high frequency of CD45RO + cells in IM were confirmed as an independent prognostic marker for DFS (p = 0.007, HR = 4.968) and OS (p = 0.007, HR = 4.957). Similar findings were observed in the multivariate analysis of the combined frequency of CD45RO+cells in IM and CT.

conclusionTILs are associated with patients clinicopathological features. Also, our findings indicate that CD45RO + TILs are a valuable marker for risk prediction in larynx SCC and could predict patients' outcomes.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsBiomarkers, TumorHumansLymphocytes, Tumor-InfiltratingPrognosisSquamous Cell Carcinoma of Head and NeckTumor MicroenvironmentBiomarkers, TumorCD45RO+ memory cellsHead and neck squamous cell carcinomaLarynx squamous cell carcinomaPrognostic markerTumor infiltrating lymphocytes

Identifiers

PMID36319566
PMCPMC9756076
OpenAlexW4306177193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.